Abstract
Finding the best treatment for a migraine patient is often a problem in clinical practice since the condition is very common and disabling. The drugs most commonly used for migraine prophylaxis are beta-blockers, calcium antagonist and serotonin modulators. Recently, several double-blind trials have affirmed the efficacy of valproic acid in migraine prophylaxis: the valproic acid is especially useful when migraine occurs in patients with epilepsy, anxiety disorders, or bipolar disorder.
Translated title of the contribution | The role of valproic acid in migraine prophylaxis |
---|---|
Original language | Italian |
Pages (from-to) | 25-27 |
Number of pages | 3 |
Journal | Bollettino - Lega Italiana contro l'Epilessia |
Issue number | 95-96 SUPPL. 1 |
Publication status | Published - 1996 |
ASJC Scopus subject areas
- Clinical Neurology